Answers are grounded in this paper and cite their sources.
Case report shows treatment improved nociception in a dog with meningoencephalomyelitis, suggesting effective immunosuppressive therapy.
A 1‐year‐old, female, spayed P1omeranian presented to the emergency service for acute paraparesis, following 3 weeks of prior weakness. Neurological examination indicated a T3–L3 myelopathy; the owners elected medical management. Three weeks later, the dog re‐presented with absent nociception in both pelvic limbs, prompting further diagnostics. Magnetic resonance imaging and cerebrospinal fluid analysis confirmed a diagnosis of meningomyelitis. Treatment began with cytosine arabinoside and dexamethasone, followed by prednisone and cyclosporine for ongoing immunosuppression. Two weeks post‐treatment, the dog regained nociception and had made a near‐complete neurological recovery, despite experiencing a relapse during treatment tapering. Unfortunately, after a total of three relapse episodes, and 15 months from the initial diagnosis, the dog was euthanased due to progression of the disease despite aggressive immunosuppressive therapy. This report describes a rare case of meningoencephalomyelitis of unknown origin with clinical signs limited to the spinal cord, which functionally recovered despite presenting with absent nociception.
No takes yet. Share an insight, caveat, or question.
Leger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: